Spots Global Cancer Trial Database for del 17p
Every month we try and update this database with for del 17p cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14) | NCT01745640 | Multiple Myelom... | POMALIDOMIDE Dexamethasone | 19 Years - | University Hospital, Lille | |
Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14) | NCT01745640 | Multiple Myelom... | POMALIDOMIDE Dexamethasone | 19 Years - | University Hospital, Lille | |
A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL | NCT00772486 | Chronic Lymphoc... | ISF35 | 18 Years - | Memgen, Inc. | |
A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL | NCT00772486 | Chronic Lymphoc... | ISF35 | 18 Years - | Memgen, Inc. |